TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
AstraZeneca AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
121,892,126
|
110,420,198
|
82,938,788 |
Financial expenses |
364,719
|
1,017,719
|
338,843 |
Earnings before taxes |
55,584,421
|
-13,807,035
|
16,739,292 |
EBITDA |
28,022,931
|
19,746,961
|
18,699,638 |
Total assets |
245,333,133
|
180,465,074
|
229,820,782 |
Current assets |
24,997,037
|
22,558,886
|
23,235,484 |
Current liabilities |
16,303,555
|
16,673,088
|
14,730,955 |
Equity capital |
208,588,979
|
141,336,810
|
190,175,180 |
- share capital |
1,379,619
|
1,372,551
|
1,493,528 |
Employees (average) |
7,248
|
6,875
|
6,814 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
85.0%
|
78.3%
|
82.7% |
Turnover per employee |
16,817
|
16,061
|
12,172 |
Profit as a percentage of turnover |
45.6%
|
-12.5%
|
20.2% |
Return on assets (ROA) |
22.8%
|
-7.1%
|
7.4% |
Current ratio |
153.3%
|
135.3%
|
157.7% |
Return on equity (ROE) |
26.6%
|
-9.8%
|
8.8% |
Change turnover |
10,903,292
|
34,199,509
|
4,932,132 |
Change turnover % |
10%
|
45%
|
6% |
Chg. No. of employees |
373
|
61
|
181 |
Chg. No. of employees % |
5%
|
1%
|
3% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.